A University of Miami Miller School of Medicine research team is launching a new study to examine the risk of atrial fibrillation — an irregular, rapid heartbeat — in patients with obstructive sleep apnea. Both conditions increase the risk of a serious stroke, according to Seemant Chaturvedi, M.D., professor of clinical neurology and Vice Chair for VA Programs in the Department of Neurology.
News : 2015
A new clinical trial at the University of Miami Miller School of Medicine will be the first in the U.S. to focus on using mesenchymal stem cells to treat Alzheimer’s disease. “We believe infusions of these types of stem cells have the potential to be beneficial to individuals with Alzheimer’s disease,” said Bernard S. Baumel, M.D., assistant professor of neurology, the principal investigator for the phase 1 clinical trial.
The Northern Manhattan Study, a collaboration between the Miller School of Medicine’s Department of Neurology and the Neurological Institute at Columbia University that started in 1990 and is believed to be the longest-running cohort study with a Hispanic majority, has received an $8.5 million, five-year NIH grant to begin a directional shift that puts new emphasis on dementia and cognitive impairment.
A new University of Miami study, aimed at identifying early signs of Alzheimer’s disease and other neurocognitive decline among Latinos and Hispanics, could help delay or even prevent its onset thanks to a $5.67 million, five-year grant from the National Institute on Aging.
A team of stroke experts from UHealth – University of Miami Health System delivered a “game-changing” treatment to 26-year-old Isabel Vinueza at Jackson Memorial Hospital, carefully removing a clot blocking the flow of blood to her brain. “This team saved my life,” Vinueza said at a Sept. 15 news conference at the University of Miami Miller School of Medicine’s Clinical Research Building.
The University of Miami Miller School of Medicine’s John P. Hussman Institute for Human Genomics hosted 14 of South Florida’s top high school seniors for the 2015 JJ Vance Memorial Summer Internship in Biological and Computational Sciences. The program provides high school students with the unique opportunity to be directly involved in scientific research.
Helen M. Bramlett, Ph.D., professor of neurosurgery and psychology, and W. Dalton Dietrich, Ph.D., Scientific Director of the Miami Project to Cure Paralysis, Senior Associate Dean for Discovery Science, and professor of neurological surgery, neurology and cell biology, have been awarded a five-year $2 million grant by the National Institute of Neurological Disorders and Stroke.
New research led by the University of Miami Miller School of Medicine suggests older people who experience migraines may have an increased risk of stroke, but only if they are smokers. The study, led by Teshamae Monteith, M.D., assistant professor of neurology, is published in the online issue of Neurology, the medical journal of the American Academy of Neurology.
The University of Miami Miller School of Medicine will collaborate with the American Heart Association/American Stroke Association as the leader of the Mild and Rapidly Improving Stroke Study – MaRISS.
Researchers at the University of Miami have discovered and characterized a previously unknown disease gene linked to the degeneration of optic and peripheral nerve fibers. The study titled “Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder” is published in the journal Nature Genetics.
The American Heart Association/American Stroke Association has issued updated guidelines for the emergency treatment of patients with acute ischemic stroke, recommending endovascular treatment using small mechanical devices known as stent retrievers that grab and allow removal of large clots from a blocked artery in the brain.
An expert committee assembled by the Institute of Medicine (IOM) has produced an important new report proposing methods for increasing survival rates and quality of life following cardiac arrest, and two prominent Miller School of Medicine physicians — cardiologist Robert J. Myerburg, M.D., and neurologist Ralph L. Sacco, M.D., M.S. — played key roles on the committee.
A team of researchers at the Sylvester Comprehensive Cancer Center and the Miller School of Medicine has discovered that a previously unappreciated so-called long noncoding RNA mechanism controls tumor growth of Glioblastoma Multiforme cells.
Ralph L. Sacco, M.D., M.S., Professor and Olemberg Chair of Neurology at the University of Miami Miller School of Medicine, has received yet another honor from the American Heart Association (AHA) for his outstanding work to reduce the risk of heart disease and stroke.
For the third straight year, UHealth – University of Miami Health System teamed up with the American Heart Association (AHA) to host the Miami-Dade and Broward Fit Friendly symposium. This year’s theme was “Creating a Culture of Health.” The event was held Thursday, June 18, at the UHealth Fitness and Wellness Center to recognize South Florida employers that create “fit friendly” workplaces.
Seemant Chaturvedi, M.D., professor of clinical neurology and Vice Chair of VA Programs in the Department of Neurology, has received a $330,000 research grant from drug-maker Boehringer Ingelheim to study new methods for preventing stroke in patients with atrial fibrillation.
Ralph L. Sacco, M.D., M.S., was honored with the Johann Jacob Wepfer Award at the 24th annual European Stroke Conference. The award is presented annually to a scientist whose outstanding scientific work in the field of cerebrovascular diseases significantly contributes to knowledge about treatment of acute stroke.
University of Miami Miller School of Medicine researchers Alejandro Caicedo, Ph.D., and Carlos T. Moraes, Ph.D., have been awarded a multiple principal investigator R33 grant from the National Institute of Environmental Health Sciences to study mitochondrial signaling in beta cells in vivo. The purpose of their research is to determine how environmental toxins affect mitochondrial function, potentially causing diabetes.
Adding to an already illustrious list of awards and accomplishments, Ralph L. Sacco, M.D., M.S., professor and Chairman of Neurology and Olemberg Family Chair of Neurological Disorders, has been named President-Elect of the American Academy of Neurology (AAN). Sacco was unanimously elected to the two-year position during the AAN’s annual meeting in Washington, D.C., on April 20.
A yearlong study of patients who had suffered from ischemic strokes, led by physician-scientists at the Interdisciplinary Stem Cell Institute at the Miller School of Medicine, has found that stem cells can be safely infused to the brain through the carotid artery within two weeks after a stroke.
Miller School of Medicine neurologist Michael Benatar, M.D., Ph.D., professor of neurology and Chief of the Neuromuscular Division of the Department of Neurology, who is the principal investigator of the CReATe Consortium, recently welcomed 60 attendees to Miami for the consortium’s first annual meeting.
A new treatment strategy for stroke patients using a retrievable stent to open large arteries in conjunction with “clot-busting” medication can dramatically reduce long-term disability, according to a ground-breaking study published online April 17 in the New England Journal of Medicine.
March is National Social Work Month, and this year’s theme is “Social Workers Pave the Way for Change.” Today, there are nearly 50 social workers on the medical campus. Some have worked here for decades and played very personal roles in the significant changes that have occurred in patient care and in the steady improvements in patient outcomes.
A team of Miller School of Medicine researchers, collaborating with investigators at other institutions, has demonstrated that the cancer drug epothilone promotes regeneration and locomotor recovery following spinal cord injury in adult rats. The research was recently published in Science.
Alberto Ramos, M.D., MSPH, assistant professor of clinical neurology at the University of Miami Miller School of Medicine, has written a corresponding editorial to the much publicized study that indicates people who sleep more than eight hours a night may have an increased risk of stroke. Both were published in the February 25 online issue of Neurology, the medical journal of the American Academy of Neurology.
The Miller School of Medicine and the Council on Foreign Relations (CFR) held a joint meeting last Friday to discuss the findings of an independent task force report, “The Emerging Global Health Crisis: Noncommunicable Diseases in Low- and Middle-Income Countries.”
Teshamae Monteith, M.D., assistant professor of neurology at the University of Miami Miller School of Medicine, was among elite company at the recent Annual Meeting of the American Association for the Advancement of Science (AAAS), an international organization dedicated to “advancing science for the benefit of all people.” The meeting is the world’s largest scientific conference.
In a study published in the February 12 issue of the journal Cell Reports, a group of University of Miami Miller School of Medicine scientists led by Antoni Barrientos, Ph.D., professor of neurology and biochemistry and molecular biology, discovered a factor that plays an essential role during the early stages of mitoribosome large-subunit assembly.
People 60 or older, especially minorities and women, have a lower risk of stroke if the top number (systolic) in their blood pressure is below 140 millimeters of mercury (mm Hg), according to a study conducted by a team of neurologists at the University of Miami Miller School of Medicine and Columbia University.
The academic journal Neurochemical Research has bestowed a rare honor upon Miller School of Medicine physician-scientist Michael D. Norenberg, M.D., professor of pathology, biochemistry and molecular biology, neurology and neurological surgery, and a member of the staff of the Miami VA Medical Center, by dedicating its February issue to his contributions to the fields of neuroscience and neuropathology.
The Division of Continuing Medical Education is hosting the Neurology Update and Stroke Intensive 2015 conference January 22 to 24 at the Mayfair Hotel and Spa in Coconut Grove.
The University of Miami Miller School of Medicine has been awarded more than $900,000 in grant awards from the Florida Department of Health to be used for projects supporting research leading to the prevention or cure of Alzheimer’s disease.